Literature DB >> 20515299

Insulin pump use in adults with type 1 diabetes--practical issues.

Greeshma Shetty1, Howard Wolpert.   

Abstract

In recent years continuous subcutaneous insulin infusion pumps have become widely adopted in many parts of the world in the treatment of type 1 diabetes in adults. A comprehensive summary of all aspects of pump therapy is beyond the scope of this article, and in this review we will focus on several practical issues that in our experience are of clinical importance in the care of patients using insulin pumps. These include: benefits and risks of pump therapy, including the use of pumps to limit hypoglycemia; individual patient considerations in choosing between pump therapy and multiple daily injections; common pump-specific etiologies of erratic glucose control, including routine clinical practices that can assist with the detection of these problems; and the use of different pump bolus types for prandial insulin coverage.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20515299     DOI: 10.1089/dia.2010.0002

Source DB:  PubMed          Journal:  Diabetes Technol Ther        ISSN: 1520-9156            Impact factor:   6.118


  8 in total

1.  Evaluation of Intradermal and Subcutaneous Infusion Set Performance Under 24-Hour Basal and Bolus Conditions.

Authors:  Elaine McVey; Steven Keith; Joshua K Herr; Diane Sutter; Ronald J Pettis
Journal:  J Diabetes Sci Technol       Date:  2015-08-27

2.  Improving the computational effort of set-inversion-based prandial insulin delivery for its integration in insulin pumps.

Authors:  Fabian León-Vargas; Remei Calm; Jorge Bondia; Josep Vehí
Journal:  J Diabetes Sci Technol       Date:  2012-11-01

Review 3.  Treating type 1 diabetes: from strategies for insulin delivery to dual hormonal control.

Authors:  A L McCall; L S Farhy
Journal:  Minerva Endocrinol       Date:  2013-06       Impact factor: 2.184

4.  Model-based sensor-augmented pump therapy.

Authors:  Benyamin Grosman; Gayane Voskanyan; Mikhail Loutseiko; Anirban Roy; Aloke Mehta; Natalie Kurtz; Neha Parikh; Francine R Kaufman; John J Mastrototaro; Barry Keenan
Journal:  J Diabetes Sci Technol       Date:  2013-03-01

5.  Opinions and Satisfaction Regarding Continuous Subcutaneous Insulin Infusion Therapy in Adult Patients with Type 1 Diabetes.

Authors:  Ikuko Nishio; Masami Chujo; Tsuyoshi Ohkura; Hideyuki Kataoka
Journal:  Yonago Acta Med       Date:  2015-10-14       Impact factor: 1.641

6.  Type 1 Diabetes Patients Using Continuous Subcutaneous Insulin Infusion Therapy: Feeling Burdened Correlated with Factors.

Authors:  Ikuko Nishio; Masami Chujo
Journal:  Yonago Acta Med       Date:  2015-10-14       Impact factor: 1.641

7.  Nonmetabolic complications of continuous subcutaneous insulin infusion: a patient survey.

Authors:  John C Pickup; Nardos Yemane; Anna Brackenridge; Siobhan Pender
Journal:  Diabetes Technol Ther       Date:  2013-11-01       Impact factor: 6.118

8.  Detailed Analysis of Insulin Absorption Variability and the Tissue Response to Continuous Subcutaneous Insulin Infusion Catheter Implantation in Swine.

Authors:  Jasmin R Hauzenberger; Brian R Hipszer; Channy Loeum; Peter A McCue; Mark DeStefano; Marc C Torjman; Mahmut T Kaner; Alek R Dinesen; Inna Chervoneva; Thomas R Pieber; Jeffrey I Joseph
Journal:  Diabetes Technol Ther       Date:  2017-10-05       Impact factor: 6.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.